Abstract
Lenar Yessayan, Balázs Szamosfalvi, Ashita Tolwani
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial
10.1001/jama.2020.18618
Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs
10.1007/s00134-015-4099-0 · 2015
Anticoagulation strategies in continuous renal replacement therapy
10.1111/sdi.12959 · 2021
Section 5: dialysis interventions for treatment of AKI
10.1038/kisup.2011.35 · 2012
A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults
10.1097/ccm.0000000000001004 · 2015
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multicenter randomized clinical trial
10.1186/s13054-014-0472-6 · 2014
Citrate anticoagulation for continuous venovenous hemofiltration
10.1097/ccm.0b013e3181953c5e · 2009
Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study
10.3310/zxhi9396 · 2022
Troubleshooting ionized hypocalcemia in patients on continuous KRT with regional citrate anticoagulation
10.34067/kid.0000001053 · 2026
Citrate: how to get started and what, when, and how to monitor?
10.2478/jtim-2018-0026 · 2018
Regional citrate anticoagulation protocol for patients with presumed absent citrate metabolism
10.34067/kid.0005342020 · 2021
A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance
10.2215/cjn.00040505 · 2006
Regional citrate anticoagulation “nonshock” protocol with precalculated flow settings for patients with at least 6 L/hour liver citrate clearance
10.1186/s12882-021-02443-6 · 2021
Management of dysnatremias with continuous renal replacement therapy
10.1111/sdi.12983 · 2021
Clinical review: Patency of the circuit in continuous renal replacement therapy
10.1186/cc5937 · 2007
Ionized hypocalcemia prior to continuous veno-venous hemodialysis initiation: prevalence and consequences
10.1186/s12871-026-03894-w · 2026
Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation
10.1097/00003246-200104000-00010 · 2001
Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients
10.1186/cc11363 · 2012
Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation
10.1016/j.jcrc.2013.10.015 · 2014
Albumin-corrected calcium ratios for citrate accumulation increase detection and improve mortality prediction in continuous kidney replacement therapy
10.1186/s13054-026-05933-x · 2026
Citrate accumulation during CRRT: the impact of diagnostic criteria
10.1186/s13054-026-05932-y · 2026
Albumin-corrected total/ionized calcium ratio is not superior to total/ionized calcium ratio as an indicator of citrate accumulation
10.5301/ijao.5000621 · 2017
Determinants of total/ionized calcium in patients undergoing citrate CVVH: a retrospective observational study
10.1016/j.jcrc.2020.05.005 · 2020
Complications of regional citrate anticoagulation: accumulation or overload?
10.1186/s13054-017-1880-1 · 2017
Incidence, severity, and predictors of citrate accumulation during continuous kidney replacement therapy in the critically ill
10.1186/s13054-025-05691-2 · 2025
Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation
10.1097/ccm.0000000000002501 · 2017
Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy
10.1177/0885066617701068 · 2019
Lactate as a predictor of citrate accumulation in patients undergoing continuous renal replacement therapy? A systematic review
10.1111/aas.70060 · 2025
Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (crrt): a delphi consensus on indications, monitoring and management
10.1186/s13054-026-06066-x · 2026
Continuous renal replacement therapy: cause and treatment of electrolyte complications
10.1111/j.1525-139x.2010.00790.x · 2010
Clinical review: anticoagulation for continuous renal replacement therapy – heparin or citrate?
10.1186/cc9358 · 2011
Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring
10.1007/s40620-020-00864-4 · 2021
Vascular access, membranes and circuit for CRRT
10.1111/sdi.12977 · 2021
Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients
10.1097/01.ccm.0000084871.76568.e6 · 2003
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
10.1186/s13054-015-1066-7 · 2015
Clinical and biological profiles associated with the time of occurrence of citrate accumulation in patients receiving continuous renal replacement therapy
10.1186/s13054-025-05648-5
Multidisciplinary guidelines on renal replacement therapy in intensive care medicine
10.1186/s13054-025-05817-6 · 2026
No additional external references are available.